相关实验视频

Updated: Jul 9, 2025

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

对针对急性髓性白血病的向疗法的比较安全性审查

Mark Dalgetty¹, Christian Leurinda¹, Jorge Cortes^1,2

¹Department of Hematology/Oncology, Medical College of Georgia, Augusta, Georgia, USA.

Expert opinion on drug safety

|November 28, 2023

概括

新的向疗法正在改善急性髓性白血病 (AML) 患者的治疗结果. 了解这些新型AML药物的独特安全概况对于有效的治疗选择和不良事件管理至关重要.

科学领域:

血液学血液学血液学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

在历史上,急性髓性白血病 (AML) 的治疗依赖于7+3化疗.
近年来,针对AML的新型向疗法激增.

研究的目的:

进行对新批准的AML药物的安全性概况进行比较分析.
提供关于AML治疗选择的临床决策信息.

主要方法:

公共数据库 (PubMed,ClinicalTrials.gov,FDA) 的文献综述. 这是一个很好的例子.
专注于2017年至2023年间批准的AML药物.

主要成果:

新型AML药物可以改善患者的治疗结果.
与标准化疗相比,这些药物具有不同的安全性和潜在不良事件.
了解这些安全问题对于患者管理至关重要.

结论:

越来越多的AML治疗方法需要对个体药物安全性的彻底了解.
早期识别和管理不良事件对于优化AML患者护理至关重要.

关键词:

急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.在CPX-351中使用.这是一种FLT3抑制剂.杰姆图祖马布 (Gemtuzumab) 是一种臭胺的药物.玻璃玻璃玻璃玻璃这是一种IDH抑制剂.威尼托克拉克斯 (Venetoclax) 是一个属于威尼托克拉克斯的地区.

更多相关视频

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...